1) Beaten down Cement stocks are witnessing fresh buying today after a long time. The market expectation that the Cement demand will improve post-monsoon. Cement stocks expected to be benefitted after gradually reopening of lockdown and an increase in construction activities. Moreover, cement stocks not yet participated in the rally of the market despite Nifty surged to a 7-month high.2) Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcement. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 lakh Covid-19 antibody tests as on September 30. Have enhanced capacity to do RT-PCR tests up to 400 per hour. Revenue for the quarter up 37% as compared to last year and up 171% as compared to the previous quarter. Expects positive for other Diagnostic stocks like Dr Lal Path lab, Metropolis and Apollo Hospital. #MOMarketUpdates #MotilalOswal #IndianStockMarket #nifty #sensex #NSE #cement #Medical #healthcare

The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation

HCL Tech Sees 2Q Rev Growth Over 3.5% Q/q in Constant Currency. Revenue growth to be a result of "broad-based momentum across all service lines, verticals and geographies," HCL Technologies Ltd. says in a statement to exchanges. Company Says EBIT margin for the current quarter is expected to be between 20.5% and 21%. "Good Booking momentum continues this quarter, led by Life Sciences & Healthcare, Telecom & Media and Financial Services verticals," HCL Tech says. "The pipeline continues to look healthy across service lines, verticals and geographies," according to the statement.TCS became the second Indian firm to attain a market valuation of over Rs 9 lakh crore after Reliance Industries. The NiftyIT Index gained today more than 4% as companies present strong quarterly results & projections. #MOMarketUpdates #MotilalOswal #NiftyIT #Indianstockmarket #Itcompanies #HCL #TCS #NSE #BSE #Infosys

1) The increasing dependency on tech due to the pandemic is resulting in better performance of IT stocks. The positive result of Accenture also resulted in fresh buying of tech stocks in Indian market. 2) Vodafone has won arbitration against India over the government's retro tax demand of Rs 20,000 crore at the Permanent Court of Arbitration in Hague on Friday. The Hague Court in its ruling said that the conduct of the Indian tax department is in breach of "fair and equitable" treatment. The Arbitration Tribunal has directed the Indian Tax Department to cease the conduct on the question. A failure to comply will engage its international responsibility. #MOMarketUpdates #MotilalOswal #Vodafone #ITstocks #Indianstockmarket #stockrecommendation #investingtips #NSE #BSE

1) Happiest Minds Technologies Ltd. debuted on the bourses at a 115% premium to its issue price AT Rs166 a share, a week after concluding its initial public offering on a remarkable note. The Rs 702-crore maiden offer was subscribed 151 times. It has gained 125% to close at Rs371 against its IPO price amid 52cr shares traded on NSE.2) Domestic Pharma major Dr Reddy closed at an all-time high of Rs4827 after the news that the Russia-based Russian Direct Investment Fund (RDIF) to distribute 10cr Covid-19 vaccine doses in India. Moreover, the Company launched Eye Allergy drop in US Market.3) SBI - The country’s largest lender State Bank of India could be sitting on a goldmine when it comes to its digital start up YONO (You only need one). The super-app could be valued at $40 billion with the lender considering long term plans to hive it off as a separate entity once it assumes a specific size- says SBI Chairman. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Nifty #sensex #IPO #Pharma #SBIYONO

HAAH Automotive Holdings Inc., a US automobile distributor, has offered to invest 300 billion won ($258 million) in Ssangyong Motor Co. as part of its bid to take a significant stake in the South Korean automaker, according to sources in the investment banking industry. Expect positive for M&M. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Mahindra

1) RBI has exempted ICICI Bank, from the Banking Regulation Act, 1949 with respect to shareholding above 30% in ICICI Lombard General Insurance and ICICI Prudential Life Insurance, for a period of three years Sept. 2023. The exemption during its operation may permit both ICICI Lombard General Insurance and/or ICICI Prudential Life to consider strategic options such as mergers and acquisitions or capital raise which have the potential of reducing the Bank’s shareholding. There would be no impact on the current distribution arrangements. This exemption will facilitate compliance with rules if there is a proposed acquisition of another general insurance business made by ICICI Lombard General Insurance. If any merger or acquisition proposal gets consummated, it will result in ICICI Bank’s shareholding in ICICI Lombard General Insurance reducing to less than 50%.2) The retail players are favourable due to the foreign equity funds investment in Indian Retail sectors.3) Ugar Sugar, Andhra Sugar, Bajaj Hindustan, Balrampur Chini, Dhampur Sugar are witnessing fresh buying after the news that the government is likely to allow sugar mills to export their Maximum Admissible Export Quantity for 2019-20 (Oct-Sep) till the end of this year, a senior government official said today. The companies will get 180 days to claim the subsidy instead of 90 days. #MOMarketUpdates #MotilalOswal #ICICIBank #SugarStocks #RetailStores #indianstockmarket #nifty #BSE #NSE